L&C Bio Co. Ltd (290650) — Financial Flexibility Index
L&C Bio Co. Ltd (290650) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of ₩6.89 Billion (operating CF ₩3.79 Billion minus capex ₩3.10 Billion) represents 0% of total liabilities (₩231.24 Billion). Check 290650 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
L&C Bio Co. Ltd Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for L&C Bio Co. Ltd across 10 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of L&C Bio Co. Ltd.
Annual Financial Flexibility Index for L&C Bio Co. Ltd (2015–2024)
Year-by-year free cash flow to debt coverage for L&C Bio Co. Ltd. Explore L&C Bio Co. Ltd (290650) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.02x | ₩-3.22 Billion | ₩-8.57 Billion | ₩191.25 Billion | ▼ -115.1% |
| 2023 | 0.11x | ₩12.85 Billion | ₩-12.13 Billion | ₩115.29 Billion | ▼ -63.9% |
| 2022 | 0.31x | ₩31.46 Billion | ₩-6.08 Billion | ₩101.77 Billion | ▼ -67.3% |
| 2021 | 0.95x | ₩21.16 Billion | ₩10.91 Billion | ₩22.38 Billion | ▲ +106.3% |
| 2020 | 0.46x | ₩10.44 Billion | ₩7.42 Billion | ₩22.77 Billion | ▼ -56.1% |
| 2019 | 1.04x | ₩8.39 Billion | ₩6.43 Billion | ₩8.04 Billion | ▼ -40.3% |
| 2018 | 1.75x | ₩8.58 Billion | ₩3.85 Billion | ₩4.92 Billion | ▲ +56.5% |
| 2017 | 1.12x | ₩4.10 Billion | ₩3.82 Billion | ₩3.68 Billion | ▲ +1086.5% |
| 2016 | 0.09x | ₩530.49 Million | ₩-185.35 Million | ₩5.64 Billion | ▲ +146.5% |
| 2015 | -0.20x | ₩-1.05 Billion | ₩-1.33 Billion | ₩5.20 Billion | — |